The Uromigos Episode 310: Dosing and Duration of Drugs From a Cost Perspective | GU Oncology Now
Daniel Goldstein returns to the podcast to discuss dosing issues and dosing changes in drugs such as nivolumab and pembrolizumab, as well as other immune checkpoint inhibitors.